Effective Non-Viral Delivery of siRNA to Acute Myeloid Leukemia Cells with Lipid-Substituted Polyethylenimines

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Landry, Breanne ^a   Aliabadi, Hamidreza Montazeri ^a   Samuel, Anuja ^a   Gül Uludaǧ, Hilal ^a   Jiang, Xiaoyan ^b   Kutsch, Olaf ^c   Uludaǧ, Hasan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; POLYETHYLENEIMINE; POLYMER; SMALL INTERFERING RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER GENE THERAPY; CELL GROWTH; CELL INTERACTION; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; GENE DELIVERY SYSTEM; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIPOPHILICITY; PROTEIN DNA BINDING; PROTEIN MODIFICATION;

CELL DEATH; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, LEUKEMIC; GENE SILENCING; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; INDICATORS AND REAGENTS; INHIBITORY CONCENTRATION 50; LEUKEMIA, MYELOID, ACUTE; LIPIDS; MICROSCOPY, ELECTRON, TRANSMISSION; POLYETHYLENEIMINE; RECEPTORS, CXCR4; RNA, SMALL INTERFERING; SERUM; TEMPERATURE; TRYPAN BLUE; VIRUSES;

EID: 84865641363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044197     Document Type: Article

References (60)

1. Cancer Facts & Figures (2012) from American Cancer Society web site. Available: http://www.cancer.org/Research/CancerFactsFigures/index. Accessed June 30, 2012.
2. Sekeres MA, (2008) Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives. Haematolog 93: 1769-1772.
3. Kasper GJ, Zwan CM, (2007) Pediatric acute myeloid leukemia:towards high quality cure of all patients. Haematolog 92: 1519-1532.
4. Löwenberg B, Downing JR, Burnett A, (2000) Acute myeloid leukemia. NEJM 341: 1051-1063.
5. Cioca DP, Aoki Y, Kiyosawa K, (2003) RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Ther 10: 125-133.
6. Greiner J, Bullinger L, Guinn B, Döhner H, Schmitt M, (2008) Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells. Clinical Cancer Research 14: 7161-7166.
7. Taratula O, Garbuzenko OB, Kirkpatrick P, Pandya I, Savla R, et al. (2009) Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J. Control Rel 140: 284-293.
8. Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, et al. (2010) ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 17: 17-23.
9. Wang B, Li S, Qi HH, Chowdhury D, Shi Y, et al. (2009) Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins. Nat Struct Mol Biol 16: 1259-1266.
10. Guo P, (2010) The emerging field of RNA nanotechnology. Nat Nanotechnol 5: 833-842.
11. Yang J-S, Hour M-J, Huang W-W, Lin K-L, Kuo S-C, et al. (2010) MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. J Pharmacol Exp Therapeut 334: 477-488.
12. Chen K-C, Liu W-H, Chang L-S, (2010) Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells. J Cell Physiol 222: 625-634.
13. Mondal S, Mandal C, Sangwan R, Chandra S, Mandal C, (2010) Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. Molecular Cancer 9: 239.
14. Liu W-H, Chang L-S, (2009) Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway. Toxicol Lett 191: 140-148.
15. Chen K-C, Liu W-H, Chang L-S, (2010) Taiwan cobra phospholipase A2-elicited JNK activation is responsible for autocrine fas-mediated cell death and modulating Bcl-2 and Bax protein expression in human leukemia K562 cells. J Cell Biochem 109: 245-254.
16. Arthanari Y, Pluen A, Rajendran R, Aojula H, Demonacos C, (2010) Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting bcr-abl fusion gene in Chronic Myeloid Leukemia cells. J Control Rel 145: 272-280.
17. Puissant A, Colosetti P, Robert G, Cassuto JP, Raynaud S, et al. (2009) Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells. Leukemia 24: 115-124.
18. Zhu Q, Shen B, Zhang B, Zhang W, Chin S, et al. (2010) Inhibition of AMP-activated protein kinase pathway sensitizes human leukemia K562 cells to nontoxic concentration of doxorubicin. Mol Cell Biochem 340: 275-281.
19. Mehrotra A, Joshi K, Kaul D, (2010) E2F-1 RNomics is critical for reprogramming of cancer cells to quiescent state. Int J Cancer 127: 849-858.
20. Koldehoff M, Kordelas L, Beelen DW, Elmaagacli AH, (2010) Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib. Haematolog 95: 388-397.
21. Aichberger KJ, Gleixner KV, Mirkina I, Cerny-Reiterer S, Peter B, et al. (2009) Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs. Blood 114: 5342-5351.
22. Seo S-B, Hur J-G, Kim M-J, Lee J-W, Kim H-B, et al. (2010) TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases. Molecular Cancer 9: 199.
23. Crombez L, Aldrian-Herrada G, Konate K, Nguyen QN, McMaster GK, et al. (2008) A New Potent Secondary Amphipathic Cell-penetrating Peptide for siRNA Delivery Into Mammalian Cells. Mol Ther 17: 95-103.
24. Wang X, Ren J, Qu X, (2008) Targeted RNA interference of cyclin A2 mediated by functionalized single-walled carbon nanotubes induces proliferation arrest and apoptosis in chronic myelogenous leukemia K562 cells. ChemMedChem 3: 940-945.
25. Aliabadi HM, Landry B, Bahadur RK, Neamnark A, Suwantong O, et al. (2011) Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers. Macromol Biosci 11: 662-672.
26. Grayson AC, Doody AM, Putnam D, (2006) Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharmaceut Res 23: 1868-1876.
27. Kwok A, Hart SL, (2011) Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine 7: 210-219.
28. Breunig M, Hozsa C, Lungwitz U, Watanabe K, Umeda I, et al. (2008) Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: Disulfide bonds boost intracellular release of the cargo. J Control Rel 130: 57-63.
29. Kloeckner J, Bruzzano S, Ogris M, Wagner E, (2006) Gene carriers based on hexanediol diacrylate linked oligoethylenimine: effect of chemical structure of polymer on biological properties. Bioconj Chem 17: 1339-1345.
30. Godbey WT, Wu KK, Mikos AG, (1999) Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci USA 96: 5177-5181.
31. Jeong JH, Song SH, Lim DW, Lee H, Park TG, (2001) DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline). J Control Rel 73: 391-399.
32. Ferrari S, Moro E, Pettenazzo A, Behr JP, Zacchello F, et al. (1997) ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Therapy 1100-1106.
33. Coll J-L, Chollet P, Brambilla E, Desplanques D, Behr J-P, et al. (1999) In Vivo Delivery to Tumors of DNA Complexed with Linear Polyethylenimine. Human Gene Therapy 10: 1659-1666.
34. Wightman L, Kircheis R, Rössler V, Carotta S, Ruzicka R, et al. (2001) Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Medicine 3: 362-372.
35. Montazeri Aliabadi H, Landry B, Mahdipoor P, Uludaǧ H, (2011) Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line. Mol Pharmaceut 8: 1821-1830.
36. Lee JS, Hmama Z, Mui A, Reiner NE, (2004) Stable gene silencing in human monocytic cell lines using lentiviral-delivered small interference RNA. J Biol Chem 279: 9379-9388.
37. Incani V, Tunis E, Clements BA, Olson C, Kucharski C, et al. (2007) Palmitic acid substitution on cationic polymers for effective delivery of plasmid DNA to bone marrow stromal cells. J Biomed Mater Res A 81A: 493-504.
38. Neamnark A, Suwantong O, Bahadur R, Hsu CY, Supaphol P, et al. (2009) Aliphatic lipid substitution on 2 kDa polyethylenimine improves plasmid delivery and transgene expression. Mol Pharmaceut 6: 1798-1815.
39. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
40. Abbasi S, Paul A, Prakash S (2011) Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer. Cell Biochem Biophys: 1-11.
41. Ouyang S-D, Pei Y-Y, Weng S-P, Lü L, Yu X-Q, et al. (2009) Effective polyethyleneimine-mediated gene transfer into zebrafish cells. Zebrafish 6: 245-251.
42. Hong S, Leroueil PR, Janus EK, Peters JL, Kober M-M, et al. (2006) Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconj Chem 17: 728-734.
43. Lima TM, Kanunfre CC, Pompéia C, Verlengia R, Curi R, (2002) Ranking the toxicity of fatty acids on Jurkat and Raji cells by flow cytometric analysis. Toxicology in Vitro 16: 741-747.
44. Shim MS, Kwon YJ, (2010) Efficient and targeted delivery of siRNA in vivo. FEBS J 277: 4814-4827.
45. Abbasi M, Lavasanifar A, Berthiaume LG, Weinfeld M, Uludaǧ H, (2010) Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells. Cancer 116: 5544-5554.
46. Zhu C, Jung S, Luo S, Meng F, Zhu X, et al. (2010) Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials 31: 2408-2416.
47. Zintchenko A, Philipp A, Dehshahri A, Wagner E, (2008) Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconj Chem 19: 1448-1455.
48. Shin J-Y, Suh D, Kim JM, Choi H-G, Kim JA, et al. (2005) Low molecular weight polyethylenimine for efficient transfection of human hematopoietic and umbilical cord blood-derived CD34+ cells. Biochimica et Biophysica Acta (BBA)- General Subjects 1725: 377-384.
49. Hartig SM, Greene RR, Carlesso G, Higginbotham JN, Khan WN, et al. (2007) Kinetic analysis of nanoparticulate polyelectrolyte complex interactions with endothelial cells. Biomaterials 28: 3843-3855.
50. Incani V, Lavasanifar A, Uludag H, (2010) Lipid and hydrophobic modification of cationic carriers on route to superior gene vectors. Soft Matter 6: 2124-2138.
51. Campbell NA, Reece JB (2002) Biology Sixth Edition: Membrane Structure and Function: Membranes Are Fluid. 6th ed: Pearson/Benjamin Cummings. 141-142.
52. Agatha G, Häfer R, Zintl F, (2001) Fatty acid composition of lymphocyte membrane phospholipids in children with acute leukemia. Cancer Letters 173: 139-144.
53. Agatha G, Voigt A, Kauf E, Zintl F, (2004) Conjugated linoleic acid modulation of cell membrane in leukemia cells. Cancer Letters 209: 87-103.
54. Tallman MS, Kim HT, Paietta E, Bennett JM, Dewald G, et al. (2004) Acute Monocytic Leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of Acute Myeloid Leukemia: a report from the Eastern Cooperative Oncology Group. J Clin Oncol 22: 1276-1286.
55. McClatchey KD (2002). Clinical Laboratory Medicine, 2nd Ed., Lippincott Williams & Wilkins, Philedelphia, PA, USA.
56. Tavor S, Petit I, Porozov S, Avigdor A, Dar A, et al. (2004) CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res 64: 2817-2824.
57. Gul H, Marquez-Curtisa LA, Jahroudi N, Larratt LM, Janowska-Wieczoreka A, (2010) Valproic acid exerts differential effects on CXCR4 expression in leukemic cells. Leukemia Research 34: 235-224.
58. Kahn J, Byk T, Jansson-Sjostrand L, Petit I, Shivtiel S, et al. (2004) Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 103: 2942-2949.
59. Persengiev SP, Zhu XC, Green MR, (2004) Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs) RNA. 10: 12-18.
60. Semizarov D, Frost L, Sarthy A, Kroeger P, Halbert DN, et al. (2003) Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci USA 100: 6347-6352.